Kanagawa K
Department of Urology, Asahikawa City Hospital, Japan.
Hokkaido Igaku Zasshi. 1995 Mar;70(2):233-40.
From March 1986 to August 1994, 110 living-related renal transplants were performed under the cyclosporine combination immunosuppression. Age of the recipients ranged from 4 to 48 years old (mean 29.3), and 81 patients were male and 29 were female. The mean duration on dialysis before the transplants were 39.7 months (0 to 210), and the methods of dialysis were divided with hemodialysis in 94 patients, CAPD in 15 and no dialysis in 1. The donors consisted of 96 parents (87.3%), 66 mothers and 30 fathers, and 14 siblings (12.7%). Age of the donors ranged from 28 to 73 years old (mean 48.7). The number of patients with acute rejection episodes were 48 patients with once, 18 with twice, 10 with 3 times and 34 (30.9%) with no rejection. Patient survival rate was 99.0% after 1 year posttransplantation, 97.9% after 3 years and 95.7% after 5 years. Graft survival rate was 91.5%, 85.1% and 77.8%, respectively. Twenty grafts were lost with the most common causes of graft loss being chronic rejection (55%), acute rejection (20%) and accelerated acute rejection (15%). In cadaveric renal transplants, because of very small number of informations for cadaver donor, only 13 cadaveric renal transplants were performed in Hokkaido, from 1984 to August 1994. There was no case over 5 years follow up postoperatively, so patient survival rate was 100% and 90% after 1 year and 3 years posttransplantation, and graft survival rate was 84.6% and 74.0%, respectively. Two kidneys of 13 cadaveric renal transplants were never functioning grafts. We have to make more efforts for propagation of the donation system.
1986年3月至1994年8月,110例亲属活体肾移植在环孢素联合免疫抑制治疗下进行。受者年龄4至48岁(平均29.3岁),男性81例,女性29例。移植前平均透析时间为39.7个月(0至210个月),透析方式为血液透析94例,持续性非卧床腹膜透析15例,未透析1例。供者包括96名父母(87.3%),其中母亲66名,父亲30名,14名兄弟姐妹(12.7%)。供者年龄28至73岁(平均48.7岁)。发生急性排斥反应的患者中,48例发生1次,18例发生2次,10例发生3次,34例(30.9%)未发生排斥反应。移植后1年患者生存率为99.0%,3年为97.9%,5年为95.7%。移植肾生存率分别为91.5%、85.1%和77.8%。20个移植肾失功,移植肾失功最常见的原因是慢性排斥反应(55%)、急性排斥反应(20%)和加速性急性排斥反应(15%)。在尸体肾移植中,由于尸体供者的信息非常少,1984年至1994年8月在北海道仅进行了13例尸体肾移植。术后无5年以上随访病例,因此移植后1年和3年患者生存率分别为100%和90%,移植肾生存率分别为84.6%和74.0%。13例尸体肾移植中有2个移植肾从未发挥功能。我们必须为捐赠系统的推广做出更多努力。